Literature DB >> 15024084

Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.

Harry A Rogoff1, Mary T Pickering, Fiona M Frame, Michelle E Debatis, Yolanda Sanchez, Stephen Jones, Timothy F Kowalik.   

Abstract

The retinoblastoma protein (Rb)/E2F pathway links cellular proliferation control to apoptosis and is critical for normal development and cancer prevention. Here we define a transcription-mediated pathway in which deregulation of E2F1 by ectopic E2F expression or Rb inactivation by E7 of human papillomavirus type 16 signals apoptosis by inducing the expression of Chk2, a component of the DNA damage response. E2F1- and E7-mediated apoptosis are compromised in cells from patients with the related disorders ataxia telangiectasia and Nijmegen breakage syndrome lacking functional Atm and Nbs1 gene products, respectively. Both Atm and Nbs1 contribute to Chk2 activation and p53 phosphorylation following deregulation of normal Rb growth control. E2F2, a related E2F family member that does not induce apoptosis, also activates Atm, resulting in phosphorylation of p53. However, we found that the key commitment step in apoptosis induction is the ability of E2F1, and not E2F2, to upregulate Chk2 expression. Our results suggest that E2F1 plays a central role in signaling disturbances in the Rb growth control pathway and, by upregulation of Chk2, may sensitize cells to undergo apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024084      PMCID: PMC371110          DOI: 10.1128/MCB.24.7.2968-2977.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  90 in total

1.  E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2.

Authors:  T F Kowalik; J DeGregori; G Leone; L Jakoi; J R Nevins
Journal:  Cell Growth Differ       Date:  1998-02

2.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

3.  Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways.

Authors:  C Barlow; K D Brown; C X Deng; D A Tagle; A Wynshaw-Boris
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

Review 4.  The p53 network.

Authors:  M L Agarwal; W R Taylor; M V Chernov; O B Chernova; G R Stark
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

5.  Distinct roles for E2F proteins in cell growth control and apoptosis.

Authors:  J DeGregori; G Leone; A Miron; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

6.  Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system.

Authors:  K F Macleod; Y Hu; T Jacks
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

7.  Role for E2F in DNA damage-induced entry of cells into S phase.

Authors:  Y Huang; T Ishiko; S Nakada; T Utsugisawa; T Kato; Z M Yuan
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

8.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

9.  DNA damage induces phosphorylation of the amino terminus of p53.

Authors:  J D Siliciano; C E Canman; Y Taya; K Sakaguchi; E Appella; M B Kastan
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

10.  Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

Authors:  T Kamijo; F Zindy; M F Roussel; D E Quelle; J R Downing; R A Ashmun; G Grosveld; C J Sherr
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

View more
  49 in total

Review 1.  E2F1: a promising regulator in ovarian carcinoma.

Authors:  Lei Zhan; Yu Zhang; Wenyan Wang; Enxue Song; Yijun Fan; Bing Wei
Journal:  Tumour Biol       Date:  2016-01-09

Review 2.  The E2F family: specific functions and overlapping interests.

Authors:  Claire Attwooll; Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

Review 3.  Opposing roles of E2Fs in cell proliferation and death.

Authors:  Meredith E Crosby; Alexandru Almasan
Journal:  Cancer Biol Ther       Date:  2004-12-21       Impact factor: 4.742

4.  Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.

Authors:  Andrés Báez-Astúa; Elsa Herráez-Hernández; Natalio Garbi; Hilda A Pasolli; Victoria Juárez; Harald Zur Hausen; Angel Cid-Arregui
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.

Authors:  Raju V Pusapati; Robert J Rounbehler; SungKi Hong; John T Powers; Mingshan Yan; Kaoru Kiguchi; Mark J McArthur; Paul K Wong; David G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 6.  Life and death decisions by the E2F transcription factors.

Authors:  Phillip J Iaquinta; Jacqueline A Lees
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

7.  Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.

Authors:  Jonathan P Castillo; Fiona M Frame; Harry A Rogoff; Mary T Pickering; Andrew D Yurochko; Timothy F Kowalik
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Cell cycle regulatory protein expression profiles by adenovirus p53 infection in human papilloma virus-associated cervical cancer cells.

Authors:  Yong-Seok Lee; Su-Mi Bae; Sun-Young Kwak; Dong-Chun Park; Yong-Wook Kim; Soo-Young Hur; Eun-Kyung Park; Byoung-Don Han; Young-Joo Lee; Chong-Kook Kim; Do Kang Kim; Woong-Shick Ahn
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

Review 9.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

10.  E2F6 inhibits cobalt chloride-mimetic hypoxia-induced apoptosis through E2F1.

Authors:  Wei-Wei Yang; Bo Shu; Yi Zhu; Huang-Tian Yang
Journal:  Mol Biol Cell       Date:  2008-06-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.